Watson Pharmaceuticals, Inc. to Present at the JP Morgan 27th Annual Healthcare Conference

CORONA, CA--(Marketwire - January 06, 2009) -

Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson’s president and chief executive officer, will provide an overview and update of the Company’s business at the JP Morgan 27th Annual Healthcare Conference on Monday, January 12, 2009 at 9:00 a.m. Pacific Standard Time.

This presentation will be webcast live and can be accessed on Watson Pharmaceuticals’ Investor Relations Web site at http://ir.watson.com. The webcast can also be accessed at the following URL:

http://metameetings.com/webcasts/jpmorgan/healthcare09/directlink?ticker=WPI

An archived version will be available for 60 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes generic and specialty brand pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

For press releases and other company information, visit Watson Pharmaceuticals’ Web site at http://www.watson.com.